Traditional Chinese medicine composition for treating chronic hepatitis B
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A chronic hepatitis B, composition technology, applied in the direction of drug combination, pharmaceutical formula, plant raw materials, etc., can solve the problems of no special effect in the treatment of hepatitis B, abnormal liver indicators, missing the best time for treatment, etc., to prevent Tendency to severe chronic hepatitis, reliable curative effect
Inactive Publication Date: 2015-08-12
李晓靖
View PDF1 Cites 2 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0002] Chronic hepatitis B is a common clinical disease and frequently-occurring disease. Its clinical symptoms are complex and diverse, including general weakness, greasy feeling, nausea, vomiting, yellow body, yellow eyes and yellow urine, etc. Some patients may not have any clinical symptoms. Abnormal liver indicators are only found during routine physical examination, and some patients even go to the hospital for diagnosis and treatment when their condition is very serious, thus missing the best time for treatment
There is currently no effective treatment for HBV
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0013] A traditional Chinese medicine composition for treating chronic hepatitis B, which is composed of the following traditional Chinese medicines in parts by weight: Bupleurum bupleuri 5g, Citrus aurantium 9g, Yuanhu 7g, turmeric 8g, woody incense 3g, Cyperus cyperi 6g, astragalus 15g, and heterophylla 5g, Atractylodes macrocephala 9g, lentils 11g, Poria 10g, Polygonum cuspidatum 8g, Smilax 18g.
Embodiment 2
[0015] A traditional Chinese medicine composition for treating chronic hepatitis B, which is composed of the following traditional Chinese medicines in parts by weight: Bupleurum bupleuri 18g, Fructus aurantium 26g, Radix chinensis 19g, Curcuma 21g, Woody 9g, Cyperus cyperi 15g, Astragalus 40g, Radix Pseudostellariae 18g, Atractylodes macrocephala 16g, lentils 27g, Poria 20g, Polygonum cuspidatum 45g, Smilax 40g.
Embodiment 3
[0017] A traditional Chinese medicine composition for treating chronic hepatitis B, which is composed of the following traditional Chinese medicines in parts by weight: Bupleurum 6g, Citrus aurantium 12g, Yuanhu 9g, Curcuma 10g, Muxiang 5g, Cyperus cyperi 7g, Astragalus 18g, Radix Pseudostellariae 8g, Atractylodes macrocephala 11g, lentils 16g, Poria cocos 14g, Polygonum cuspidatum 12g, Smilax tuckahoe 23g.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a traditional Chinese medicine composition for treating chronic hepatitis B. The traditional Chinese medicine composition is composed of the following traditional Chinese medicines by weight: 5-18g of radix bupleuri, 9-26g of bitter orange, 7-19g of rhizoma corydalis, 8-21g of radix curcumae, 3-9g of elecampane, 6-15g of rhizoma cyperi, 15-40g of Astragalus membranaceus, 5-18g of radix pseudostellariae, 9-16g of white atractylodes rhizome, 11-27g of hyacinth bean, 10-20g of Tuckahoe, 8-45g of giant knot weed, and 18-40g of rhizoma smilacis glabrae, furthermore, the traditional Chinese medicine composition is composed of the following traditional Chinese medicines by weight: 6-13g of radix bupleuri, 12-19g of bitter orange, 9-16g of rhizoma corydalis, 10-17g of radix curcumae, 5-7g of elecampane,7-12g of rhizoma cyperi, 18-30g of Astragalus membranaceus, 8-16g of radix pseudostellariae, 11-15g of white atractylodes rhizome, 16-23g of hyacinth bean, 14-18g of Tuckahoe, 12-30g of giant knot weed, and 23-36g of rhizoma smilacis glabrae.
Description
technical field [0001] The invention relates to a traditional Chinese medicine composition, in particular to a traditional Chinese medicine composition for treating chronic hepatitis B. Background technique [0002] Chronic hepatitis B is a common clinical disease and frequently-occurring disease. Its clinical symptoms are complex and diverse, including general weakness, greasy feeling, nausea, vomiting, yellow body, yellow eyes and yellow urine, etc. Some patients may not have any clinical symptoms. Abnormal liver indicators were only discovered during routine physical examination, and some patients even went to the hospital for diagnosis and treatment when their condition was very serious, thus missing the best time for treatment. There is currently no effective treatment for hepatitis B. Contents of the invention [0003] The purpose of the invention is to provide a traditional Chinese medicine composition with good curative effect for treating chronic hepatitis B. ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more